Naveen Pemmaraju, Professor at the Department of Leukemia of MD Anderson Cancer Center, shared a post on X:
“The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms.”
Title: The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms
Journal: Leukemia
Authors: Michael W. M. Kühn, Naveen Pemmaraju , Florian H. Heidel
More posts featuring Naveen Pemmaraju on OncoDaily